Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2010, Article ID 358534, 5 pages
http://dx.doi.org/10.1155/2010/358534
Clinical Study

Eye Movement Impairment Recovery in a Gaucher Patient Treated with Miglustat

1Department of Electronics (DEEI), University of Trieste, 34127 Trieste, Italy
2Department of Ophthalmology, IRCCS “Burlo Garofolo”, 34137 Trieste, Italy
3Metabolic Diseases Unit, IRCCS “Burlo Garofolo”, 34137 Trieste, Italy

Received 22 March 2010; Revised 6 July 2010; Accepted 8 September 2010

Academic Editor: Dirk Deleu

Copyright © 2010 Agostino Accardo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Hoffmann and E. Mayatepek, “Neurological manifestations in lysosomal storage disorders—from pathology to first therapeutic possibilities,” Neuropediatrics, vol. 36, no. 5, pp. 285–289, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Shafit-Zagardo, E. A. Devine, and M. Smith, “Assignment of the gene for acid β-glucosidase to human chromosome 1,” American Journal of Human Genetics, vol. 33, no. 4, pp. 564–575, 1981. View at Google Scholar
  3. M. C. Patterson, M. Horowitz, R. B. Abel et al., “Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher's disease,” Neurology, vol. 43, no. 10, pp. 1993–1997, 1993. View at Google Scholar · View at Scopus
  4. J. O. King, “Progressive myoclonic epilepsy due to Gaucher's disease in an adult,” Journal of Neurology Neurosurgery and Psychiatry, vol. 38, no. 9, pp. 849–854, 1975. View at Google Scholar · View at Scopus
  5. M. D. Winkelman, B. Q. Banker, M. Victor, and H. W. Moser, “Non-infantile neuronopathic Gaucher's disease: a clinicopathologic study,” Neurology, vol. 33, no. 8, pp. 994–1008, 1983. View at Google Scholar · View at Scopus
  6. J. K. Park, E. Orvisky, N. Tayebi et al., “Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup,” Pediatric Research, vol. 53, no. 3, pp. 387–395, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. D. G. Cogan, F. Chu, D. Reingold, and J. Barranger, “Ocular motor signs in some metabolic diseases,” Archives of Ophthalmology, vol. 99, no. 10, pp. 1802–1808, 1981. View at Google Scholar · View at Scopus
  8. J. H. Tripp, B. D. Lake, and E. Young, “Juvenile Gaucher's disease with horizontal gaze palsy in three siblings,” Journal of Neurology Neurosurgery and Psychiatry, vol. 40, no. 5, pp. 470–478, 1977. View at Google Scholar · View at Scopus
  9. R. N. Nishimura and J. A. Barranger, “Neurologic complications of Gaucher's disease, type 3,” Archives of Neurology, vol. 37, no. 2, pp. 92–93, 1980. View at Google Scholar · View at Scopus
  10. C. M. Harris, F. Shawkat, I. Russell-Eggitt, J. Wilson, and D. Taylor, “Intermittent horizontal saccade failure (‘ocular motor apraxia’) in children,” British Journal of Ophthalmology, vol. 80, no. 2, pp. 151–158, 1996. View at Google Scholar · View at Scopus
  11. S. Garbutt and C. M. Harris, “Abnormal vertical optokinetic nystagmus in infants and children,” British Journal of Ophthalmology, vol. 84, no. 5, pp. 451–455, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Garbutt, M. R. Harwood, and C. M. Harris, “Comparison of the main sequence of reflexive saccades and the quick phases of optokinetic nystagmus,” British Journal of Ophthalmology, vol. 85, no. 12, pp. 1477–1483, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. A. P. Accardo, S. Pensiero, and P. Perissutti, “Saccadic analysis for early identification of neurological involvement in Gaucher disease,” Annals of the New York Academy of Sciences, vol. 1039, pp. 503–507, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Sidransky, “Gaucher disease: complexity in a “simple” disorder,” Molecular Genetics and Metabolism, vol. 83, no. 1-2, pp. 6–15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. G. M. Pastores, N. L. Barnett, P. Bathan, and E. H. Kolodny, “A neurological symptom survey of patients with type I Gaucher disease,” Journal of Inherited Metabolic Disease, vol. 26, no. 7, pp. 641–645, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Parenti, M. Filocamo, L. Titomanlio et al., “A novel mutation of the β-glucocererebrosidase gene associated with neurologic manifestations in three sibs,” Clinical Genetics, vol. 53, no. 4, pp. 281–285, 1998. View at Google Scholar · View at Scopus
  17. P. Chérin, C. Rose, C. de Roux-Serratrice et al., “The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG),” Journal of Inherited Metabolic Disease, vol. 33, no. 4, pp. 331–338, 2010. View at Publisher · View at Google Scholar
  18. N. J. Weinreb, J. Charrow, H. C. Andersson et al., “Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher registry,” American Journal of Medicine, vol. 113, no. 2, pp. 112–119, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Schiffmann, M. P. Heyes, J. M. Aerts et al., “Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease,” Annals of Neurology, vol. 42, no. 4, pp. 613–621, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Vellodi, A. Tylki-Szymanska, E. H. Davies et al., “Management of neuronopathic Gaucher disease: revised recommendations,” Journal of Inherited Metabolic Disease, vol. 32, no. 5, pp. 660–664, 2009. View at Publisher · View at Google Scholar
  21. U. H. Schueler, T. Kolter, C. R. Kaneski, G. C. Zirzow, K. Sandhoff, and R. O. Brady, “Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease,” Journal of Inherited Metabolic Disease, vol. 27, no. 5, pp. 649–658, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Cox, R. Lachmann, C. Hollak et al., “Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis,” The Lancet, vol. 355, no. 9214, pp. 1481–1485, 2000. View at Google Scholar · View at Scopus
  23. J. L. Capablo, R. Franco, A. S. de Cabezón, P. Alfonso, M. Pocovi, and P. Giraldo, “Neurologic improvement in a type 3 Gaucher disease patient treated with imiglucerase/miglustat combination,” Epilepsia, vol. 48, no. 7, pp. 1406–1408, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Schiffmann, E. J. Fitzgibbon, C. Harris et al., “Randomized, controlled trial of miglustat in Gaucher's disease type 3,” Annals of Neurology, vol. 64, no. 5, pp. 514–522, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. P. Accardo, S. Pensiero, S. Da Pozzo, and P. Perissutti, “Some characteristics of saccadic eye movements in children of primary school age,” Documenta Ophthalmologica, vol. 80, no. 2, pp. 189–199, 1992. View at Google Scholar · View at Scopus
  26. A. Accardo, B. Bembi, S. Pensiero, and P. Perissutti, “Type 3 Gaucher's disease in a three-year-old child: saccadic eye movements analysis,” Journal of AAPOS, vol. 9, no. 5, pp. 501–503, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Filocamo, R. Mazzotti, M. Stroppiano et al., “Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian gaucher patients,” Human Mutation, vol. 20, no. 3, pp. 234–235, 2002. View at Google Scholar · View at Scopus
  28. P. E. Campbell, C. M. Harris, and A. Vellodi, “Deterioration of the auditory brainstem response in children with type 3 Gaucher disease,” Neurology, vol. 63, no. 2, pp. 385–387, 2004. View at Google Scholar · View at Scopus
  29. C. M. Harris, D. S. I. Taylor, and A. Vellodi, “Ocular motor abnormalities in Gaucher disease,” Neuropediatrics, vol. 30, no. 6, pp. 289–293, 1999. View at Google Scholar · View at Scopus
  30. S. Pensiero, A. Accardo, M. G. Pittis, G. Ciana, B. Bembi, and P. Perissutti, “Saccade testing in the diagnosis and treatment of type 3 Gaucher disease,” Neurology, vol. 65, no. 11, p. 1837, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. O. Goker-Alpan, R. Schiffmann, J. K. Park, B. K. Stubblefield, N. Tayebi, and E. Sidransky, “Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3,” Journal of Pediatrics, vol. 143, no. 2, pp. 273–276, 2003. View at Publisher · View at Google Scholar · View at Scopus